Metropolis Healthcare Limited

₹576.90As of Sun 8 Nov 2026, 12:00 UTC
NSE:METROPOLISHealthcare
Country India
PE (Fwd) •••
TSR 8Y CAGR 12.92%
Div yield 0.35%
ROE 14.56%
Diagnostics & Research
Beta (5Y) 0.22
PE TTM 53.26
TSR TTM 17.59%
Mkt cap ₹119.7B
ROIC 14.93%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹582
0.94%
(73.14%)
Hold 5|8|1|2|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
5.03
4.80
4.69
4.71
(0.99%)
(10.42%)
(8.18%)
(6.20%)
Revenue₹B
8.569
8.385
8.370
8.300
2.01%
(3.89%)
(2.97%)
(2.28%)
Peers (US$1.262B)
Cap (US$)
PE
1.613B
74.47x
1.279B
19.87x
Capital
TTM
5Y
10Y
Leveragex
3.579
(0.181)
(0.214)
EBIT/Intx
0.597
0.151
0.156
Own earn%
131.31
57.41
50.25
Sh yield%
17.35
32.54
32.44
Owners
Insiders/Inst%
1.67
34.13
Short interest%
1.31
SBC / revenue%
1.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
7–15
$1 testx
—
Incr. ROIC%
7